Novomix 50 Penfill (Insulin Aspart)

Novomix 50 Penfill is a rapid‑acting insulin analogue used in the management of blood glucose levels in diabetes mellitus. It is indicated for:

• Type 1 diabetes mellitus: improves post‑prandial glucose control.
• Type 2 diabetes mellitus: assists in achieving target fasting and post‑prandial glucose levels.
• Gestational diabetes mellitus: helps maintain maternal glycaemic control when diet alone is insufficient.
• Pre‑operative fasting: provides basal insulin coverage during surgical fasting periods.
• Intensive insulin therapy: used as part of a basal‑bolus regimen for tight glycaemic control.
• Pediatric diabetes: suitable for children requiring rapid‑acting insulin.

• Insulin aspart is a modified human insulin molecule with a single amino‑acid substitution that reduces self‑association, allowing rapid absorption after subcutaneous injection. It binds to insulin receptors on muscle and adipose cells, activating the receptor’s tyrosine kinase pathway, which promotes glucose uptake, glycogen synthesis and inhibition of hepatic glucose production, thereby lowering blood glucose concentrations.

Novomix 50 Penfill may cause a range of adverse reactions.

Common Side Effects

• Hypoglycaemia: low blood sugar levels.
• Injection site reactions: redness, swelling, or itching.
• Lipodystrophy: localized fat tissue changes.
• Weight gain: increase in body weight.
• Fluid retention: mild peripheral oedema.

Serious or Rare Side Effects

• Severe hypoglycaemia with neuroglycopenic symptoms.
• Anaphylactic reaction: hives, swelling, difficulty breathing.
• Acute allergic dermatitis.
• Insulin antibody formation that interferes with glucose control.
• Persistent hyperglycaemia despite therapy.

When using Novomix 50 Penfill, several safety considerations are important.

• Hypoglycaemia risk: monitor blood glucose regularly and adjust dose as needed.
• Dose adjustments: required during illness, stress, or changes in physical activity.
• Pregnancy and lactation: use only if clearly needed and prescribed.
• Renal or hepatic impairment: may need dose modification.
• Concomitant medications: assess for drugs that alter glucose metabolism.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Novomix 50 Penfill can interact with several drug classes, affecting glucose control.

Major Interactions (Avoid)

• Beta‑beta beta beta beta beta beta beta beta beta beta beta beta beta beta beta beta beta beta beta beta beta beta beta beta beta beta beta beta beta beta beta beta beta beta beta beta beta beta beta beta beta beta beta beta beta beta beta beta beta beta beta beta beta beta beta beta beta beta beta beta beta beta beta beta beta beta beta beta beta beta beta ...
• ...

Moderate ");